About AAIC 2026
Join distinguished basic scientists, clinical researchers, early career investigators, clinicians and the care research community at the largest international conference on dementia science. Share theories, breakthroughs and best practices while exploring opportunities to accelerate your work and elevate your career.
Conference Program
Take a look at the robust program of scientific sessions, networking opportunities and events at AAIC:
- Schedule at a Glance
- Plenary Sessions
- Scientific Sessions
- ISTAART Programming
- AAIC For All: Clinicians
View the addenda for changes to the printed program.
Download the Attendee Mobile App
On-site attendees: Simplify and enhance your AAIC experience by downloading the ALZ Meetings app, which allows you to build your daily schedule, review abstracts and much more. Learn how to download the app.
See What's Happening at AAIC
Mind the gap… The ISTAART Networking Reception helps researchers from around the world bridge the gap between strangers and future collaborators.
From breakthrough findings to fresh ideas, over 7,800 submitted abstracts mean there’s no shortage of posters to explore in our Exhibit Hall.
When the brightest minds in dementia science gather, powerful conversations become tomorrow’s breakthroughs.
Takaomi C. Saido presents his plenary, “From Curiosity to Cure: The Neprilysin-Donanemab and Amyloid Beta-Tau Axes in Alzheimer’s Disease.”
Betty Tijms presents her plenary, "Proteomic Subtypes of AD: What Do They Mean and How Will They Influence or Benefit Drug Development for Alzheimer's Disease?"
Seeing London through a different lens! These attendees embraced the spirit of the Welcome Reception with silly glasses, laughter and a memorable walk through the city.
London called, and you answered! Over 12,000 of the brightest minds in dementia science and clinical practice are joining us in London.
Ganesh Babulal receives the Bill Thies Award for Distinguished Service to ISTAART in recognition of his tireless dedication, leadership and lasting contributions to the ISTAART community.
Suzanne E. Schindler presents the first plenary session on day two of AAIC: "Eligibility for Anti-Amyloid Immunotherapy: Amyloid Biomarkers in the Real World."
Exploring the evolving landscape of dementia in Latin America, Daisy Acosta presents new findings from the landmark 10/66 Studies, shedding light on prevalence, risk factors and the path forward.